Table 1 Effects of first-line therapy with bromocriptine, pergolide or cabergoline on tumor size and prolactin levels in patients with macroprolactinomas [7–9]
| Â | Bromocriptine (n = 27) | Pergolide (n = 22) | Cabergoline (n = 26) |
|---|---|---|---|
Baseline prolactin (μg/L) | 2260 | 2938 | 1013 |
Normalized prolactin (% of patients) | 66 | 68 | 100 |
≥50% tumor reduction (% of patients) | 64 | 86 | 96 |
Duration of treatment (months) | 12 | 27 | 24 |